123 related articles for article (PubMed ID: 3145997)
1. [Improvement in anti-hemophilic preparations and its problems. 5. Stability and oral administration of factor VIII and IX concentrates].
Oguma Y; Shimizu K; Sakuragawa N
Rinsho Ketsueki; 1988 May; 29(5):655-61. PubMed ID: 3145997
[No Abstract] [Full Text] [Related]
2. [Improvement in anti-hemophilic preparations and its problems. 3. Treatment of hemophilia patients with inhibitors; induction of immune tolerance by a low or intermediate dose regimen].
Iizuka A
Rinsho Ketsueki; 1988 May; 29(5):640-8. PubMed ID: 3145995
[No Abstract] [Full Text] [Related]
3. Clotting factor concentrates for resistant haemophilia.
Bloom AL
Br J Haematol; 1978 Sep; 40(1):21-7. PubMed ID: 361064
[No Abstract] [Full Text] [Related]
4. Intensive factor replacement for management of chronic synovitis in hemophilic children.
Miser AW; Miser JS; Newton WA
Am J Pediatr Hematol Oncol; 1986; 8(1):66-9. PubMed ID: 3087226
[No Abstract] [Full Text] [Related]
5. Therapy for AHF and PTC hemophilia. II.
Seeler RA
IMJ Ill Med J; 1970 Jun; 137(6):598-602 passim. PubMed ID: 4393113
[No Abstract] [Full Text] [Related]
6. Specific therapy in hemophilia.
Hutaff LW
N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809
[No Abstract] [Full Text] [Related]
7. Laboratory and clinical evaluation of concentrates for treatment of haemophilia.
Verstraete M; Vermylen J
Acta Clin Belg; 1975; 30(5):437-48. PubMed ID: 1221749
[No Abstract] [Full Text] [Related]
8. [Improvement in anti-hemophilic preparations and its problems. 7. Present status and future aspect of anti-hemophilic preparations].
Kamiya T
Rinsho Ketsueki; 1988 May; 29(5):666-70. PubMed ID: 3145998
[No Abstract] [Full Text] [Related]
9. [Oral administration of factor VIII or IX concentrate preparation].
Sakuragawa N
Rinsho Ketsueki; 1985 Jul; 26(7):1086-9. PubMed ID: 3932721
[No Abstract] [Full Text] [Related]
10. Factor VIII inhibitor treatment with high doses of F VIII.
Stenbjerg S; Ingerslev J; Zachariae E
Thromb Res; 1984 Jun; 34(6):533-9. PubMed ID: 6429891
[TBL] [Abstract][Full Text] [Related]
11. [New strategies of treatment of hemophilia].
Yoshioka A
Rinsho Ketsueki; 2000 May; 41(5):365-9. PubMed ID: 10879092
[No Abstract] [Full Text] [Related]
12. The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy.
Pierce GF; Lusher JM; Brownstein AP; Goldsmith JC; Kessler CM
JAMA; 1989 Jun; 261(23):3434-8. PubMed ID: 2498537
[TBL] [Abstract][Full Text] [Related]
13. Hemophilia.
Tintinalli JE
JACEP; 1977 Jul; 6(7):326-9. PubMed ID: 875253
[No Abstract] [Full Text] [Related]
14. Plasma clearance rates of coagulation factors VIII and IX in factor-deficient individuals.
Noe DA; Bell WR; Ness PM; Levin J
Blood; 1986 Apr; 67(4):969-72. PubMed ID: 3082391
[TBL] [Abstract][Full Text] [Related]
15. [Odontological problems in patients with hemophilia].
Giuliano L; Saracini A; Bertolotto C
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):145-58. PubMed ID: 6443703
[No Abstract] [Full Text] [Related]
16. [Therapy of immuninhibitor hemophilia A with FEIBA plasma fraction].
István L; Bariska I; Marton E
Orv Hetil; 1980 Dec; 121(51):3131-5. PubMed ID: 6784062
[No Abstract] [Full Text] [Related]
17. [Recent findings on hemophilia].
Abe T; Kinoshita T
Nihon Rinsho; 1981; 39(12):3647-56. PubMed ID: 6803031
[No Abstract] [Full Text] [Related]
18. [Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates].
Ikematsu S; Yorifuji H; Arai M; Fukutake K
Rinsho Ketsueki; 1988 May; 29(5):628-34. PubMed ID: 3145993
[No Abstract] [Full Text] [Related]
19. [Treatment of hemophilia].
Straub PW
Dtsch Med Wochenschr; 1969 Sep; 94(37):1885-7. PubMed ID: 5356323
[No Abstract] [Full Text] [Related]
20. [New viewpoints in the treatment of hemophilia].
Göbel U
Dtsch Med Wochenschr; 1973 Sep; 98(39):1814-6. PubMed ID: 4583442
[No Abstract] [Full Text] [Related]
[Next] [New Search]
